Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

Robert J. Motzer, Thomas E. Hutson, Hilary Glen, M. Dror Michaelson, Ana M. Molina, Timothy Eisen, Jacek Jassem, Jakub Żołnierek, Begoña Mellado, Bohuslav Melichar,

The Lancet Oncology · 2015 · 943 citations · 17 references

DOIFull text

Open access

Concepts

References

17